Cargando…
Curcumin reverses doxorubicin resistance via inhibition the efflux function of ABCB4 in doxorubicin-resistant breast cancer cells
Doxorubicin is one of the most widely used chemotherapy agents for the treatment of breast cancer. However, the development of doxorubicin resistance limits the long-term treatment benefits in patients with breast cancer. Curcumin, a well-known dietary polyphenol derived from the rhizomes of turmeri...
Autores principales: | Wen, Chunjie, Fu, Lijuan, Huang, Jiafeng, Dai, Yi, Wang, Bin, Xu, Ge, Wu, Lanxiang, Zhou, Honghao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522915/ https://www.ncbi.nlm.nih.gov/pubmed/31059026 http://dx.doi.org/10.3892/mmr.2019.10180 |
Ejemplares similares
-
MDR1 Inhibition Reverses Doxorubicin-Resistance in Six Doxorubicin-Resistant Canine Prostate and Bladder Cancer Cell Lines
por: Packeiser, Eva-Maria, et al.
Publicado: (2023) -
STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1
por: Li, Zhaoqing, et al.
Publicado: (2021) -
Salinomycin enhances doxorubicin-induced cytotoxicity in multidrug resistant MCF-7/MDR human breast cancer cells via decreased efflux of doxorubicin
por: KIM, KWANG-YOUN, et al.
Publicado: (2015) -
Reversal of doxorubicin-resistance by Salvia miltiorrhiza ligustrazine in the SHG44/doxorubicin glioma drug-resistant cell line
por: Wang, Feng, et al.
Publicado: (2017) -
Corrigendum: STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1
por: Li, Zhaoqing, et al.
Publicado: (2022)